Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus [Phase 2]
A Phase 2a multicenter randomized, double-blind, placebo-controlled study assessing the efficacy and safety of VENT-03 in adults with active…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants [Phase 3]
Phase 3 pediatric trial evaluating intravenous anifrolumab for systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of KITE-363 in Participants With Refractory Autoimmune Diseases [Phase 1]
Phase 1 study evaluating KITE-363 in participants with refractory autoimmune diseases, currently enrolling by invitation, including systemic…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD [Phase 2]
This is a Phase 2 clinical trial assessing whether anifrolumab improves vascular risk markers in systemic lupus erythematosus; the study is …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) [Phase 3]
A Phase 3 clinical trial evaluating Enpatoran for cutaneous lupus manifestations with or without systemic lupus erythematosus is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease [Phase 3]
A Phase 3 clinical trial evaluating enpatoran for cutaneous lupus manifestations in patients with or without systemic lupus erythematosus is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating YKST02 alone or in combination with YK012 for active or refractory systemic lupus erythematosus; the stu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Systemic Lupus Erythematosus
This clinical trial update indicates that a study evaluating systemic lupus erythematosus, sponsored by NIAMS, is currently recruiting parti…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Dose Response of Exercise for Arthritis Management [NA]
A University of South Carolina-led clinical trial is investigating the dose-response effects of exercise on arthritis management and related…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) [Phase 1]
Phase 1 trial update evaluating intravenous ABBV-319 in adults with systemic lupus erythematosus and Sjögren's syndrome, focusing on adverse…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial to evaluate the efficacy and safety of Dapirolizumab Pegol in participants with moderately to severely active syste…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of TQH3906 for systemic lupus erythematosus. The study is not yet recruiting …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants [Phase 2]
Phase 2 study to evaluate the efficacy, safety, and pharmacokinetics of obinutuzumab in adolescents with active Class III/IV lupus nephritis…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Cenerimod for systemic lupus erythematosus; the study is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease [EARLY_Phase 1]
An early-phase trial of allogeneic CD19/BCMA CAR-T therapy for B-cell–related autoimmune diseases is recruiting at The Children's Hospital o…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus [Phase 2]
Phase 2 clinical trial update evaluating SG301 SC injection for systemic lupus erythematosus is currently recruiting to assess efficacy and …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial evaluating the oral medicine Cenerimod for adults with systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus [Phase 1]
A Phase 1 clinical trial assessing safety, tolerability, drug levels and effects of BMS-986326 in adults with lupus, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) [Phase 1]
This is a Phase 1 clinical trial evaluating MK-1045 in people with systemic lupus erythematosus or rheumatoid arthritis. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 clinical trial update for CPTX2309, an investigational therapy, evaluating safety in healthy participants and in individuals with rh…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus [Phase 2]
Phase 2 clinical trial update on Frexalimab (SAR441344) for systemic lupus erythematosus, highlighting ongoing assessment of efficacy and sa…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Descartes-08 for Patients With Systemic Lupus Erythematosus [Phase 2]
Descartes-08 is being tested in a Phase 2 trial for systemic lupus erythematosus, and the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) [Phase 1]
Climb Bio, Inc. announced a Phase 1b clinical trial evaluating Budoprutug in adults with systemic lupus erythematosus, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the efficacy and safety of Cenerimod in active lupus nephritis on top of standard therapy…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) [Phase 1]
A Phase 1 study evaluating HB2198 in adults with systemic lupus erythematosus, including lupus nephritis, is currently recruiting.